Daimroc Imaging LLC

Neurokappa Therapeutics LLC is a Philadelphia-based company comprised of a team of scientists and business professionals dedicated to developing innovative medications for neurological diseases such as stroke, pain, and addiction. Leveraging their deep understanding of opioid receptors, they aim to create novel compounds that target these receptors, with potential therapeutic applications in stroke therapy, pain management, depression, and addiction therapy. The company's vision is to provide an effective alternative pathway for delivering medications for neurological diseases, particularly in out-of-hospital settings where intravenous access may not be readily available. With a focus on prioritizing the efficacy of action over the mechanism of actions, Neurokappa Therapeutics LLC is committed to continuously pursuing both scientific discoveries and the development of new indications for existing medications.Generated from the website

Carisma Therapeutics Inc. is a Philadelphia-based biotech company that is revolutionizing cancer treatment through the development of CAR-Macrophages, a groundbreaking approach to immunotherapy. By engineering monocytes and macrophages to attack tumors, Carisma's innovative cellular therapies have the potential to deliver long-term anti-tumor immunity and significantly improve patient outcomes. With a focus on leveraging advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy, Carisma's unique therapeutic approach engages both the innate and adaptive immune systems to launch a multi-pronged attack on tumors. By addressing key challenges faced by current cell therapies, such as tumor infiltration, immunosuppressive tumor microenvironments, and antigen heterogeneity, Carisma is at the forefront of developing life-changing treatments for patients with cancer and other serious disorders.Generated from the website

Spark Therapeutics, Inc., based in Philadelphia, PA, is a pioneering gene therapy company dedicated to transforming healthcare through innovative genetic treatments. With a focus on inherited diseases such as inherited retinal diseases, hemophilia, and neurodegenerative disorders, Spark combines cutting-edge vector design, advanced manufacturing capabilities, and a strong commitment to improving patient care. Through their fully integrated approach, Spark Therapeutics aims to unlock the potential of gene therapy to create groundbreaking medicines that address unmet medical needs. Their mission is to lead the way in gene therapy innovation, driving healthcare transformation and sparking change in the local community through collaboration and excellence in research, development, and commercial operations.Generated from the website